How have IBDV shares performed in 2024?

iShares iBonds Dec 2030 Term Corporate ETF's stock was trading at $21.64 at the beginning of 2024. Since then, IBDV stock has decreased by 3.6% and is now trading at $20.86. View the best growth stocks for 2024 here .

How often does iShares iBonds Dec 2030 Term Corporate ETF pay dividends? What is the dividend yield for iShares iBonds Dec 2030 Term Corporate ETF?

iShares iBonds Dec 2030 Term Corporate ETF announced a dividend on Thursday, November 23rd. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.0846 per share on Friday, April 5th. The ex-dividend date of this dividend is Monday, April 1st. This is a boost from the stock's previous dividend of $0.07. Read our dividend analysis for IBDV .

What does IBDV invest in?

iShares iBonds Dec 2030 Term Corporate ETF is a fixed income fund issued by iShares. IBDV focuses on investment grade investments and follows the Bloomberg December 2030 Maturity Corporate Index (USD). The fund's investments total to approximately $885.61 million assets under management.

What is the management fee for iShares iBonds Dec 2030 Term Corporate ETF?

iShares iBonds Dec 2030 Term Corporate ETF's management fee is 0.10% and has no other recorded expenses or fee waivers. The net expense ratio for IBDV is 0.10%.

What other stocks do shareholders of iShares iBonds Dec 2030 Term Corporate ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iShares iBonds Dec 2030 Term Corporate ETF investors own include Abiomed (ABMD) , Catalent (CTLT) , Hologic (HOLX) , Merck & Co., Inc. (MRK) , Net Element (NETE) , Novavax (NVAX) , Quanterix (QTRX) , ARCA biopharma (ABIO) , AbbVie (ABBV) and AudioEye (AEYE) .

Who are iShares iBonds Dec 2030 Term Corporate ETF's major shareholders?

iShares iBonds Dec 2030 Term Corporate ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Buffington Mohr McNeal (3.15%), Praetorian Wealth Management Inc. (0.67%), Gradient Capital Advisors LLC (0.12%), Adirondack Trust Co. (0.08%), Montecito Bank & Trust (0.08%) and Bank of New Hampshire (0.08%).

How do I buy shares of iShares iBonds Dec 2030 Term Corporate ETF?

Shares of IBDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSEARCA:IBDV

iShares iBonds Dec 2030 Term Corporate ETF (IBDV) Price, Holdings, & News

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free IBDV Stock Alerts

$20.86

+0.02 (+0.10%)

(As of 04/19/2024 ET)

Compare

Today's Range: $20.84
▼
$20.88
50-Day Range: $20.82
▼
$21.45
52-Week Range: $19.82
▼
$22.33

Volume: 163,434 shs
Average Volume: 255,052 shs
Market Capitalization: $389.04 million

Assets Under Management: $885.61 million
Dividend Yield: 3.02%
Net Expense Ratio: 0.10%

Stock Analysis Chart Dividend Holdings Ownership

Get iShares iBonds Dec 2030 Term Corporate ETF alerts:

About iShares iBonds Dec 2030 Term Corporate ETF

The iShares iBonds Dec 2030 Term Corporate ETF (IBDV) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg index of USD-denominated, investment-grade corporate bonds maturing between Jan 1 and Dec 15, 2029. IBDV was launched on Jun 23, 2020 and is managed by BlackRock.

IBDV Stock Price History

30 days | 90 days | 365 days | Advanced Chart

IBDV ETF News Headlines

April 1, 2024 | msn.com

iShares iBonds Dec 2024 Term Muni Bond ETF declares monthly distribution of $0.0408

April 1, 2024 | msn.com

iShares iBonds Dec 2030 Term Treasury ETF declares monthly distribution of $0.0667

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

February 13, 2024 | finance.yahoo.com

iShares iBonds Dec 2030 Term Corporate ETF (IBDV)

See More Headlines

Receive IBDV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares iBonds Dec 2030 Term Corporate ETF and its competitors with MarketBeat's FREE daily newsletter.

Fund Details

Issuer: iShares
Fund Name: iShares iBonds Dec 2030 Term Corporate ETF
Tax Classification: Regulated Investment Company
Stock Exchange: NYSEARCA
Current Symbol: NYSEARCA:IBDV
Inception Date: 6/23/2020
Fund Manager: James Mauro, Scott Radell
Web: N/A
Phone: N/A

Fund Focus

Asset Class: Fixed Income
Benchmark: Bloomberg December 2030 Maturity Corporate Index (USD)
Category: Corporate
Focus: Investment Grade
Development Level: Developed Markets
Region: North America
Number of Holdings: 501

Fund Statistics

Assets Under Management: $885.61 million
Average Daily Volume: $0.00
Discount/Premium: 0.03%

Administrator, Advisor and Custodian

Administrator: State Street Bank and Trust Company
Advisor: BlackRock Fund Advisors
Custodian: State Street Bank and Trust Company
Distributor: BlackRock Investments, LLC
Transfer Agent: State Street Bank and Trust Company
Trustee: N/A
Lead Market Maker: Virtu Financial

Options

Optionable: N/A
Short Interest: 49,300 shs

Miscellaneous

Outstanding Shares: 18,650,000
Beta: 0.34
Creation Unit: 50,000
Creation Fee: $425.00

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

iShares iBonds Dec 2030 Term Corporate ETF Expenses

Type	IBDV	Investment Grade ETFs	Fixed Income ETFs	NYSEARCA ETFs	All ETFs
Management Fee	0.10%	0.22%	0.32%	0.50%	0.51%
Other Expenses	0.00%	0.12%	0.27%	0.64%	0.58%
Total Expense	0.10%	0.25%	0.40%	0.74%	0.70%
Fee Waiver	0.00%	-0.15%	-0.24%	-0.68%	-0.57%
Net Expense	0.10%	0.22%	0.35%	0.58%	0.58%

iShares iBonds Dec 2030 Term Corporate ETF (IBDV) Holdings & Exposure

Top 10 IBDV Holdings

T-MOBILE USA INC - 3.88 2030-04-15
Holding Weight: 1.71%
BOEING CO - 5.15 2030-05-01
Holding Weight: 1.15%
DEUTSCHE TELEKOM INTERNATIONAL FIN - 8.75 2030-06-15
Holding Weight: 1.11%
BRITISH TELECOMMUNICATIONS PLC - 9.63 2030-12-15
Holding Weight: 0.89%
AT&T INC - 4.3 2030-02-15
Holding Weight: 0.83%
AMGEN INC - 5.25 2030-03-02
Holding Weight: 0.78%
ORACLE CORPORATION - 2.95 2030-04-01
Holding Weight: 0.75%
PACIFIC GAS AND ELECTRIC COMPANY - 4.55 2030-07-01
Holding Weight: 0.74%
HSBC HOLDINGS PLC - 4.95 2030-03-31
Holding Weight: 0.69%
OCCIDENTAL PETROLEUM CORPORATION - 6.63 2030-09-01
Holding Weight: 0.67%

IBDV Sector Exposure

IBDV Industry Exposure

Full Holdings Details

Similar ETFs

Institutional Ownership

View All Institutional Transactions

IBDV ETF - Frequently Asked Questions

How have IBDV shares performed in 2024?: iShares iBonds Dec 2030 Term Corporate ETF's stock was trading at $21.64 at the beginning of 2024. Since then, IBDV stock has decreased by 3.6% and is now trading at $20.86.
View the best growth stocks for 2024 here.
How often does iShares iBonds Dec 2030 Term Corporate ETF pay dividends? What is the dividend yield for iShares iBonds Dec 2030 Term Corporate ETF?: iShares iBonds Dec 2030 Term Corporate ETF announced a dividend on Thursday, November 23rd. Shareholders of record on Tuesday, April 2nd will be given a dividend of $0.0846 per share on Friday, April 5th. The ex-dividend date of this dividend is Monday, April 1st. This is a boost from the stock's previous dividend of $0.07.
Read our dividend analysis for IBDV.
What does IBDV invest in?: iShares iBonds Dec 2030 Term Corporate ETF is a fixed income fund issued by iShares. IBDV focuses on investment grade investments and follows the Bloomberg December 2030 Maturity Corporate Index (USD). The fund's investments total to approximately $885.61 million assets under management.
What is the management fee for iShares iBonds Dec 2030 Term Corporate ETF?: iShares iBonds Dec 2030 Term Corporate ETF's management fee is 0.10% and has no other recorded expenses or fee waivers. The net expense ratio for IBDV is 0.10%.

What other stocks do shareholders of iShares iBonds Dec 2030 Term Corporate ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iShares iBonds Dec 2030 Term Corporate ETF investors own include Abiomed (ABMD), Catalent (CTLT), Hologic (HOLX), Merck & Co., Inc. (MRK), Net Element (NETE), Novavax (NVAX), Quanterix (QTRX), ARCA biopharma (ABIO), AbbVie (ABBV) and AudioEye (AEYE).
Who are iShares iBonds Dec 2030 Term Corporate ETF's major shareholders?: iShares iBonds Dec 2030 Term Corporate ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Buffington Mohr McNeal (3.15%), Praetorian Wealth Management Inc. (0.67%), Gradient Capital Advisors LLC (0.12%), Adirondack Trust Co. (0.08%), Montecito Bank & Trust (0.08%) and Bank of New Hampshire (0.08%).
How do I buy shares of iShares iBonds Dec 2030 Term Corporate ETF?: Shares of IBDV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSEARCA:IBDV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial